<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

true
true

CLAIM ID

3122117c

During the lockdown, the Ministry of Environment, Forests and Climate Change panels cleared or discussed 30 projects in biodiverse forests.

The MoEFCC has accorded clearances and discussed 30 projects in biodiverse forests during the lockdown period.

The MoEFCC has accorded clearances and discussed 30 projects in biodiverse forests during the lockdown period.Jairam Ramesh, the chairman of the Parliamentary Standing Committee on Environment, Forests, and Climate Changer raised strong objections to clearances given to projects by various panels of the Ministry of Environment and Forests during the COVID-19 lockdown and sought a review and a moratorium on them. He was referring to reports that various panels of the Ministry of Environment, Forests and Climate Change(MoEFCC) have granted approvals and discussed projects in biodiverse forests during the lockdown period.

MoEFCC's official website reveals the various projects that were cleared Terms of Reference(ToR) by the Expert Appraisal Committees during the lockdown. ToRs are guidelines for administering environmental studies of projects after which the project is considered for clearance by the committee.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.